Anti-Human KLKB1 Recombinant Antibody
-
产品编号
YR1413
-
别名
科研级 Lanadelumab ( 拉那鲁单抗 ), Anti-KLKB1 Recombinant Antibody, Research Grade Lanadelumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Lanadelumab ( 拉那鲁单抗 ), Anti-KLKB1 Recombinant Antibody, Research Grade Lanadelumab |
| Catalog Number | YR1413 |
| Molecular Name | Lanadelumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Lanadelumab (INN, trade name Takhzyro) is a human monoclonal antibody (class IgG1 kappa) that targets plasma kallikrein (pKal) in order to promote prevention of angioedema in patients with hereditary angioedema. |
| CAS Number | 1426055-14-2 |
| Application | ELISA, IHC, FCM, IP, IF, FuncS, PK |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | KLKB1[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
